Dr. Aleksandra Dukic

University of Oslo

A Novel Target to Inhibit Glioblastoma Invasion

Dr. Aleksandra Dukic, postdoctoral researcher, Institute for Cancer Research, Oslo University Hospital, describes a novel target for inhibiting glioblastoma cancer invasion into surrounding brain tissue and the importance of this work in addressing the need for innovative therapeutics to combat this aggressive cancer. Hear how the culture and analysis of glioblastoma patient-derived cells are vital to her work.

LIKE 1


Dr. Aleksandra Dukic
Neuroscience Cell Culture

Dr. Aleksandra Dukic

Biography

Dr. Aleksandra Dukic's current project focuses on a novel target for inhibiting glioblastoma cancer invasion. More
Follow Aleksandra

Dr. Aleksandra Dukic

University of Oslo

Aleksandra completed her Bachelor and Master’s degree in Molecular Biology at the University of Novi Sad, Novi Sad, Serbia in 2012, where she worked on cAMP signaling in testosterone-producing Leydig cells (Laboratory for Reproductive Endocrinology and Signaling). In 2013, she started her PhD at the University of Oslo in Kjetil Tasken group (Centre for Molecular Medicine Norway), focusing on A-kinase anchoring protein complex and regulation of gap junction intercellular communication. She obtained her PhD degree in Molecular cell biology at the Faculty of Medicine, University of Oslo in 2016. Aleksandra continued as a PostDoc in Tasken lab and applied knowledge from her PhD projects on an innovation, drug discovery project in cancer field, targeting gap junctions with small molecular compounds. The current project focuses on a novel target for inhibiting glioblastoma cancer invasion. The group is at present located in the Institute for Cancer Research, Oslo University Hospital.